- Report
- October 2023
- 140 Pages
Global
From €2388EUR$2,499USD£2,032GBP
- Report
- May 2024
- 181 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- May 2024
- 93 Pages
Global
From €5352EUR$5,600USD£4,553GBP
- Report
- May 2024
- 130 Pages
Global
From €6211EUR$6,499USD£5,284GBP
- Report
- April 2024
- 136 Pages
Global
From €3726EUR$3,899USD£3,170GBP
- Report
- February 2024
- 175 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- January 2024
- 175 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- January 2024
- 175 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- January 2024
- 200 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- November 2023
- 190 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- March 2024
- 150 Pages
Global
From €4960EUR$5,190USD£4,220GBP
- Report
- December 2023
- 150 Pages
Global
From €3472EUR$3,633USD£2,954GBP
€4960EUR$5,190USD£4,220GBP
- Report
- February 2024
- 188 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- February 2024
- 184 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- November 2023
- 181 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- November 2023
- 188 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- April 2024
- 185 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- October 2023
- 181 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- February 2024
- 110 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Report
- February 2024
- 110 Pages
Global
From €4539EUR$4,750USD£3,862GBP
The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more